Gilead statement on the @NEJM publication of data from the NIAID study of our investigational antiviral drug to treat COVID-19: https://bit.ly/2Zts19B.
A recent interview with our CSO @Dr_Nick_Bikes on emerging themes in NK cell cancer immunology and why big pharma have turned their attention to NK cells as drug targets in oncology
Juggling multiple hot topics this week... in our latest KOL interview @3NT discusses CAR-NK cell therapies with @Dr_Nick_Bikes - the field is moving along nicely! https://pxlme.me/3PajEUd9 Zooms are so much more fun that battling the crazy conference crowds too ;)
https://www.aacr.org/about-the-aacr/newsroom/news-releases/dr-steven-a-rosenberg-recognized-with-the-2020-aacr-cri-lloyd-j-old-award-in-cancer-immunology/?utm_medium=linkedin&utm_source=social&utm_campaign=pressrelease&utm_content=lloydaward&sf122097145=1 Very well deserved. From the @oNKo_innate team, a huge congratulations to Steven Rosenberg @NIH, a pioneer in immune cell therapy on the @CancerResearch Lloyd J Old award for 2020